![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Julius Baer Group Ltd (PK) | USOTC:JBAXY | OTCMarkets | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.57 | 11.52 | 11.69 | 11.66 | 11.5675 | 11.63 | 39,632 | 21:01:20 |
1611 GMT [Dow Jones] SMI ends 0.9% lower at 7796.84. ABB, which had reported disappointing earnings Thursday, falls 1.1% after announcing the completion of an acquisition in the US. Novartis and Roche shed 1.2% and 0.7% respectively. Credit Suisse manages a 0.1% gain following a warm appraisal of 2Q results from Fitch. Fellow banks UBS and Julius Baer drop 0.5% and 0.1% respectively. The broader market also slides, with the SPI falling 0.8%. Galenica bucks the trend, rising 8% after winning US FDA approval for an anemia drug. (zurichdjnews@dowjones.com)
Contact us in London. +44-20-7842-9464 Markettalk.eu@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Julius Baer (PK) Chart |
1 Month Julius Baer (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions